Toll-like  	Toll-like  	 JJ	B-NP
receptor  	receptor  	 NN	I-NP
4  	4  	 CD	I-NP
( 	( 	 -LRB-	O
TLR4 	TLR4 	 NNP	B-NP
)  	)  	 -RRB-	O
gene  	gene  	 NN	B-NP
polymorphisms  	polymorphisms  	 NN	I-NP
in  	in  	 IN	O
giant  	giant  	 JJ	B-NP
cell  	cell  	 NN	I-NP
arteritis  	arteritis  	 NN	I-NP
To  	To  	 TO	O
investigate  	investigate  	 VB	O
potential  	potential  	 JJ	B-NP
associations  	associations  	 NNS	I-NP
between  	between  	 IN	O
toll-like  	toll-like  	 JJ	B-NP
receptor  	receptor  	 NN	I-NP
4  	4  	 CD	I-NP
( 	( 	 -LRB-	O
TLR4 	TLR4 	 NNP	B-NP
)  	)  	 -RRB-	O
gene  	gene  	 NN	B-NP
polymorphisms  	polymorphisms  	 NNS	I-NP
and  	and  	 CC	O
susceptibility  	susceptibility  	 JJ	O
to 	to 	 TO	O
,  	,  	 ,	O
and  	and  	 CC	O
clinical  	clinical  	 JJ	B-NP
features  	features  	 NNS	I-NP
of  	of  	 IN	I-NP
giant  	giant  	 JJ	I-NP
cell  	cell  	 NN	I-NP
arteritis  	arteritis  	 NNS	I-NP
( 	( 	 -LRB-	O
GCA 	GCA 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
A  	A  	 DT	O
total  	total  	 NN	O
of  	of  	 IN	O
155  	155  	 CD	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
biopsy-proven  	biopsy-proven  	 JJ	B-NP
GCA  	GCA  	 NNS	I-NP
who  	who  	 WP	O
were  	were  	 VBD	O
residents  	residents  	 NNS	O
of  	of  	 IN	O
Reggio  	Reggio  	 NNP	O
Emilia 	Emilia 	 NNP	O
,  	,  	 ,	O
Italy 	Italy 	 NNP	O
,  	,  	 ,	O
and  	and  	 CC	O
210  	210  	 CD	O
population-based  	population-based  	 JJ	B-NP
controls  	controls  	 NNS	I-NP
from  	from  	 IN	O
the  	the  	 DT	O
same  	same  	 JJ	O
geographical  	geographical  	 JJ	B-NP
area  	area  	 NN	I-NP
were  	were  	 VBD	O
genotyped  	genotyped  	 VBN	O
for  	for  	 IN	O
two  	two  	 CD	O
coding  	coding  	 CD	O
single  	single  	 JJ	O
nucleotide  	nucleotide  	 JJ	B-NP
polymorphisms  	polymorphisms  	 NN	I-NP
of  	of  	 IN	I-NP
TLR4  	TLR4  	 NNP	I-NP
( 	( 	 -LRB-	O
Asp299Gly  	Asp299Gly  	 NNP	O
and  	and  	 CC	O
Thr399Ile 	Thr399Ile 	 CD	O
)  	)  	 -RRB-	O
by  	by  	 IN	O
molecular  	molecular  	 JJ	B-NP
methods 	methods 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
patients  	patients  	 NNS	O
were  	were  	 VBD	O
subgrouped  	subgrouped  	 VBN	O
according  	according  	 VBG	O
to  	to  	 TO	O
the  	the  	 DT	O
presence  	presence  	 NN	O
or  	or  	 CC	O
absence  	absence  	 NN	B-NP
of  	of  	 IN	I-NP
polymyalgia  	polymyalgia  	 JJ	I-NP
rheumatica  	rheumatica  	 NN	I-NP
and  	and  	 CC	O
severe  	severe  	 JJ	O
ischemic  	ischemic  	 JJ	B-NP
complications  	complications  	 NNS	I-NP
( 	( 	 -LRB-	O
visual  	visual  	 JJ	O
loss  	loss  	 NN	O
and 	and 	 CC	O
/ 	/ 	 NNP	O
or  	or  	 CC	O
cerebrovascular  	cerebrovascular  	 JJ	B-NP
accidents 	accidents 	 NNS	I-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
distribution  	distribution  	 NN	B-NP
of  	of  	 IN	I-NP
allele  	allele  	 NN	I-NP
and  	and  	 CC	O
genotype  	genotype  	 JJ	B-NP
frequencies  	frequencies  	 NN	I-NP
did  	did  	 VBD	O
not  	not  	 RB	O
differ  	differ  	 VBP	O
significantly  	significantly  	 RB	O
between  	between  	 IN	O
GCA  	GCA  	 NNP	B-NP
patients  	patients  	 NNS	I-NP
and  	and  	 CC	O
healthy  	healthy  	 JJ	O
controls 	controls 	 NNS	O
.  	.  	 .	O
Carriers  	Carriers  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
-299  	-299  	 NNP	O
G  	G  	 NNP	B-NP
allele  	allele  	 NNS	I-NP
( 	( 	 -LRB-	O
G 	G 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
A+  	A+  	 NNP	I-NP
G 	G 	 NNP	O
/ 	/ 	 NNP	O
G 	G 	 NNP	O
)  	)  	 -RRB-	O
[ 	[ 	 -LRB-	O
odds  	odds  	 JJ	B-NP
ratio  	ratio  	 NN	I-NP
( 	( 	 -LRB-	O
OR 	OR 	 NNP	B-NP
)  	)  	 -RRB-	O
1.78 	1.78 	 CD	O
,  	,  	 ,	O
95 	95 	 CD	O
%  	%  	 NN	O
confidence  	confidence  	 NN	B-NP
intervals  	intervals  	 NNS	I-NP
( 	( 	 -LRB-	O
CI 	CI 	 NNP	B-NP
)  	)  	 -RRB-	O
0.90-3.50 	0.90-3.50 	 CD	O
) 	) 	 -RRB-	O
]  	]  	 -RRB-	O
were  	were  	 VBD	O
more  	more  	 RBR	O
frequent  	frequent  	 JJ	O
among  	among  	 IN	O
GCA  	GCA  	 NNP	B-NP
patients  	patients  	 NNS	I-NP
than  	than  	 IN	O
among  	among  	 IN	O
the  	the  	 DT	O
controls 	controls 	 NNS	O
,  	,  	 ,	O
but  	but  	 CC	O
the  	the  	 DT	O
difference  	difference  	 NN	O
was  	was  	 VBD	O
not  	not  	 RB	O
statistically  	statistically  	 RB	O
significant 	significant 	 JJ	O
.  	.  	 .	O
No  	No  	 DT	O
significant  	significant  	 JJ	O
associations  	associations  	 NNS	B-NP
were  	were  	 VBD	O
found  	found  	 VBN	O
when  	when  	 WRB	O
GCA  	GCA  	 NNP	B-NP
patients  	patients  	 NNS	I-NP
with  	with  	 IN	O
and  	and  	 CC	O
without  	without  	 IN	O
PMR  	PMR  	 NNP	B-NP
or  	or  	 CC	O
with  	with  	 IN	O
and  	and  	 CC	O
without  	without  	 IN	O
severe  	severe  	 JJ	O
ischemic  	ischemic  	 JJ	B-NP
complications  	complications  	 NNS	I-NP
were  	were  	 VBD	O
compared 	compared 	 VBN	O
.  	.  	 .	O
Our  	Our  	 PRP$	O
data  	data  	 NNS	O
suggest  	suggest  	 VBP	O
that  	that  	 IN	O
the  	the  	 DT	O
TLR4  	TLR4  	 JJ	B-NP
gene  	gene  	 NN	I-NP
polymorphisms  	polymorphisms  	 NNS	I-NP
are  	are  	 VBP	O
not  	not  	 RB	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
susceptibility  	susceptibility  	 VBG	O
to 	to 	 TO	O
,  	,  	 ,	O
and  	and  	 CC	O
clinical  	clinical  	 JJ	B-NP
expression  	expression  	 NN	I-NP
of 	of 	 IN	O
,  	,  	 ,	O
GCA  	GCA  	 NNP	B-NP
in  	in  	 IN	O
Italian  	Italian  	 JJ	O
patients 	patients 	 NNS	O
.  	.  	 .	O
